SPYH.DE vs. CIB0.DE
SPYH.DE (State Street SPDR MSCI Europe Health Care UCITS ETF) and CIB0.DE (VanEck Bionic Engineering UCITS ETF A) are both Health & Biotech Equities funds - SPYH.DE tracks the MSCI Europe Health Care 35/20 Capped Index while CIB0.DE tracks the MVIS Global Bionic Healthcare ESG. Both are passively managed. Over the past 3 years, SPYH.DE returned 5.66%/yr vs -7.77%/yr for CIB0.DE. At a 0.39 correlation, their price movements are largely independent. SPYH.DE charges 0.18%/yr vs 0.55%/yr for CIB0.DE.
Performance
SPYH.DE vs. CIB0.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SPYH.DE achieves a 3.28% return, which is significantly higher than CIB0.DE's -11.68% return.
SPYH.DE
- 1D
- 1.55%
- 1M
- 4.04%
- YTD
- 3.28%
- 6M
- 3.42%
- 1Y
- 16.39%
- 3Y*
- 5.66%
- 5Y*
- 5.89%
- 10Y*
- 7.26%
CIB0.DE
- 1D
- 0.00%
- 1M
- 2.50%
- YTD
- -11.68%
- 6M
- -11.71%
- 1Y
- -10.87%
- 3Y*
- -7.77%
- 5Y*
- —
- 10Y*
- —
SPYH.DE vs. CIB0.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
SPYH.DE State Street SPDR MSCI Europe Health Care UCITS ETF | 3.28% | 7.82% | 3.98% | 7.88% | -2.32% |
CIB0.DE VanEck Bionic Engineering UCITS ETF A | -11.68% | -10.00% | 5.16% | 2.09% | -8.46% |
Correlation
The correlation between SPYH.DE and CIB0.DE is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.45 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.38 |
Correlation (All Time) Calculated using the full available price history since Dec 2, 2022 | 0.39 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPYH.DE vs. CIB0.DE — Risk / Return Rank
SPYH.DE
CIB0.DE
SPYH.DE vs. CIB0.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for State Street SPDR MSCI Europe Health Care UCITS ETF (SPYH.DE) and VanEck Bionic Engineering UCITS ETF A (CIB0.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SPYH.DE | CIB0.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.58 | ||
| Sortino ratioReturn per unit of downside risk | +2.28 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 0.91 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 1.30 | -0.47 | +1.76 |
| Martin ratioReturn relative to average drawdown | 2.95 | -1.10 | +4.05 |
Loading charts...
Drawdowns
SPYH.DE vs. CIB0.DE - Drawdown Comparison
The maximum SPYH.DE drawdown since its inception was -26.62%, smaller than the maximum CIB0.DE drawdown of -32.60%. Use the drawdown chart below to compare losses from any high point for SPYH.DE and CIB0.DE.
Loading charts...
Drawdown Indicators
| SPYH.DE | CIB0.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.62% | -32.60% | +5.98% |
Max Drawdown (1Y)Largest decline over 1 year | -12.58% | -23.47% | +10.89% |
Max Drawdown (3Y)Largest decline over 3 years | -26.62% | -32.60% | +5.98% |
Max Drawdown (5Y)Largest decline over 5 years | -26.62% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -26.62% | — | — |
Current DrawdownCurrent decline from peak | -5.94% | -26.17% | +20.23% |
Average DrawdownAverage peak-to-trough decline | -7.67% | -11.12% | +3.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.54% | 9.91% | -4.37% |
Volatility
SPYH.DE vs. CIB0.DE - Volatility Comparison
State Street SPDR MSCI Europe Health Care UCITS ETF (SPYH.DE) has a higher volatility of 6.37% compared to VanEck Bionic Engineering UCITS ETF A (CIB0.DE) at 5.47%. This indicates that SPYH.DE's price experiences larger fluctuations and is considered to be riskier than CIB0.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SPYH.DE | CIB0.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.37% | 5.47% | +0.90% |
Volatility (6M)Calculated over the trailing 6-month period | 12.59% | 12.99% | -0.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.23% | 17.33% | -0.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.82% | 18.05% | -2.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.83% | 18.05% | -2.22% |
SPYH.DE vs. CIB0.DE - Expense Ratio Comparison
SPYH.DE has a 0.18% expense ratio, which is lower than CIB0.DE's 0.55% expense ratio.
Dividends
SPYH.DE vs. CIB0.DE - Dividend Comparison
Neither SPYH.DE nor CIB0.DE has paid dividends to shareholders.
Frequently Asked Questions
SPYH.DE and CIB0.DE have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SPYH.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SPYH.DE is cheaper with a 0.18% expense ratio, compared with 0.55% for CIB0.DE.
SPYH.DE tracks MSCI Europe Health Care 35/20 Capped Index, while CIB0.DE tracks MVIS Global Bionic Healthcare ESG. They also come from different issuers: State Street and VanEck. Their fees differ too: 0.18% for SPYH.DE and 0.55% for CIB0.DE.
Find the right allocation for SPYH.DE and CIB0.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer